Olmesartan Medoxomil in Atherosclerosis

Clinical trial NCT00185185 · COMPLETED

Trial details

NCT number: NCT00185185
Sponsor: Sankyo Pharma Gmbh
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension Atherosclerotic Cardiovascular Disease

Start date: 2001-11-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.